| Identification | |
| Name: | 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,3-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl] 5-methyl ester |
| Synonyms: | 2-(4-(Diphenylmethyl)-1-piperazinyl)ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| CAS: | 89226-50-6 |
| Molecular Formula: | C35H38N4O6 |
| Molecular Weight: | 610.7 |
| InChI: | InChI=1/C35H38N4O6/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-16,23,32-33,36H,17-22H2,1-3H3 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.232 g/cm3 |
| Specification: | Light Yellow Crystalline Solid usageEng:A dihydropyridine calcium channel blocker. Antihypertensive |
| Usage: | A dihydropyridine calcium channel blocker. Antihypertensive |
| Safety Data | |
 |
|
